Document Detail

Elevated troponin predicts long-term adverse cardiovascular outcomes in hypertensive crisis: a retrospective study.
MedLine Citation:
PMID:  22990357     Owner:  NLM     Status:  Publisher    
BACKGROUND:: Hypertensive crisis is associated with poor clinical outcomes. Elevated troponin, frequently observed in hypertensive crisis, may be attributed to myocardial supply-demand mismatch or obstructive coronary artery disease (CAD). However, in patients presenting with hypertensive crisis and an elevated troponin, the prevalence of CAD and the long-term adverse cardiovascular outcomes are unknown. OBJECTIVE:: We sought to assess the impact of elevated troponin on cardiovascular outcomes and evaluate the role of troponin as a predictor of obstructive CAD in patients with hypertensive crisis. METHODS:: Patients who presented with hypertensive crisis (n = 236) were screened retrospectively. Baseline and follow-up data including the event rates were obtained using electronic patient records. Those without an assay for cardiac Troponin I (cTnI) (n = 65) were excluded. Of the remaining 171 patients, those with elevated cTnI (cTnI ≥ 0.12 ng/ml) (n = 56) were compared with those with normal cTnI (cTnI < 0.12 ng/ml) (n = 115) at 2 years for the occurrence of major adverse cardiac or cerebrovascular events (MACCE) (composite of myocardial infarction, unstable angina, hypertensive crisis, pulmonary edema, stroke or transient ischemic attack). RESULTS:: At 2 years, MACCE occurred in 40 (71.4%) patients with elevated cTnI compared with 44 (38.3%) patients with normal cTnI [hazard ratio: 2.77; 95% confidence interval (CI): 1.79-4.27; P < 0.001]. Also, patients with elevated cTnI were significantly more likely to have underlying obstructive CAD (odds ratio: 8.97; 95% CI: 1.4-55.9; P < 0.01). CONCLUSION:: In patients with hypertensive crisis, elevated cTnI confers a significantly greater risk of long-term MACCE, and is a strong predictor of obstructive CAD.
Deepak J Pattanshetty; Pradeep K Bhat; Ashish Aneja; Dilip P Pillai
Related Documents :
24676777 - Impaired glucose regulation predicted 1-year mortality of chinese patients with ischemi...
1897687 - Increased chemokinetic and chemotactic responses of eosinophils in asthmatic patients.
19352297 - Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associ...
24151507 - Coagulopathy and extremely elevated pt/inr after dabigatran etexilate use in a patient ...
18096447 - The bravo ph capsule system.
3153277 - Therapy of focal segmental glomerulosclerosis with cyclosporine a.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-15
Journal Detail:
Title:  Journal of hypertension     Volume:  -     ISSN:  1473-5598     ISO Abbreviation:  J. Hypertens.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8306882     Medline TA:  J Hypertens     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
The Heart and Vascular Center, MetroHealth Campus of Case Western Reserve University, Cleveland, Ohio, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reference values of aortic pulse wave velocity in a large healthy population aged between 3 and 18 y...
Next Document:  The fetal origins of hypertension: a systematic review and meta-analysis of the evidence from animal...